Dominant-negative transforming growth factor-β receptor-armoured mesothelin-targeted chimeric antigen receptor T cells slow tumour growth in a mouse model of ovarian cancer

Ke Li(Shanghai Medical College of Fudan University), Yu Kang(Obstetrics and Gynecology Hospital of Fudan University)
Cancer Immunology Immunotherapy
September 27, 2022
Cited by 24


Related Papers